Retatrutide
Triple GIP / GLP-1 / glucagon agonist.
A triple-receptor agonist targeting GIP, GLP-1 and glucagon pathways — a next-generation subject of metabolic-peptide research.
Purity
≥99% (HPLC)
Presentations
10 mg · 20 mg
Format
Research use only
Retatrutide · RD-16In research terms
How it's
understood.
Engages three complementary receptors at once, studied for combined effects on energy expenditure, satiety and glucose handling.
Descriptions summarise published research context only. Nothing here is dosing guidance or a claim of any effect in humans.
Where it's studied
Triple-agonist signalling models
Energy-expenditure research
Comparative incretin studies
Research use only
For laboratory research. Not for human consumption.
Retatrutide is supplied to researchers and institutions for in-vitro and laboratory study. Need a certificate of analysis or handling detail for Retatrutide? Get in touch.
Request documentation →Related compounds
View all →
All products listed are supplied strictly for laboratory and research use only. They are not dietary supplements, medicines or foods, and are not intended for human or veterinary consumption, diagnosis or treatment. This website is informational and does not offer products for sale.